Business and Finance News 24/7
A groundbreaking drug recently approved by the Food and Drug Administration is proving to be revolutionary in the treatment of Alzheimer’s disease, offering hope and transformative results for patients. One hospital in Region 8 is at the forefront of providing this life-changing medical care, and patients are experiencing remarkable benefits. Norma Lee, an 80-year-old resident […]
Continue Reading
Federal authorities are addressing concerns after the confirmation of the second-ever case of a human contracting the “highly pathogenic” bird flu in the United States, reported in Texas on Monday. The infected individual, identified as a dairy worker, exhibited minor symptoms and has received treatment, according to the Texas Department of State Health Services. Despite […]
Continue Reading
The Digital Pathology Market is expected to witness a growth rate of ~10.5% by 2029. The key factors driving the market are the rising incidence of chronic illnesses like cancer, diabetes, and cardiovascular conditions, the expanding utilization of digital pathology in research, the growing integration of digital pathology in drug discovery and precision medicine initiatives, […]
Continue Reading
The Cardiology Information System (CIS) Market is poised for remarkable growth, with an anticipated Compound Annual Growth Rate (CAGR) of 8-10% during the forecast period. This surge is primarily attributed to the escalating incidence of cardiovascular diseases, including coronary artery disease (CAD) and strokes. The market expansion is further fueled by the pressing need for […]
Continue Reading
Unlock the potential of clinical research with the surge in Global Decentralized Clinical Trials, forecasted to reach $14.2 billion by 2026. Discover how digital advancements and strategic collaborations are reshaping the future of patient-centric healthcare. Market Overview The Global Decentralized Clinical Trials (DCTs) Market, initially valued at $8.8 billion in 2021, stands on the brink […]
Continue Reading
The Breast Imaging Market is anticipated to witness a robust growth trajectory, with a projected Compound Annual Growth Rate (CAGR) of 7-9% during the forecast period from 2023 to 2028. This growth is fueled by several factors including the increasing prevalence of breast cancer, heightened focus on contrast-based diagnostic solutions, conducive environments for funding and […]
Continue Reading
The transplantation market, encompassing organ and tissue transplantation, is poised for substantial growth between 2024 and 2029, with a projected Compound Annual Growth Rate (CAGR) of 9-10%. This surge is propelled by various factors such as technological advancements, increasing prevalence of chronic diseases leading to organ failure, rising awareness about transplantation, and evolving regulatory landscape. […]
Continue Reading
Researchers at the Fred Hutchinson Cancer Center in Seattle have recently conducted a study that reveals a potential connection between oral bacteria and the acceleration of colon cancer growth. Published in Nature, the research underscores the existence of a specific oral bacterium, Fusobacterium nucleatum, in colon tumor tissues and its association with tumor growth. After […]
Continue Reading
The global Cell and Gene Therapy CDMO market is on an unprecedented growth trajectory, projected to witness a staggering Compound Annual Growth Rate (CAGR) of approximately 25%, with estimates suggesting it will reach a monumental $5 billion by 2025. This surge is primarily attributed to the escalating burden of cancer and other targeted diseases, the […]
Continue Reading
In a landmark decision, the U.S. Food and Drug Administration (FDA) has given the green light to Lenmeldy (atidarsagene autotemcel), marking a significant breakthrough as the inaugural FDA-sanctioned gene therapy for children grappling with metachromatic leukodystrophy (MLD). MLD is a rare genetic disorder that makes people unable to function properly. It affects the brain and […]
Continue Reading